aeruginosa infection, we orally applied ciprofloxacin concurrently with intraperitoneally administered IL-17A–neutralizing antibody in COPD mouse models starting at 16 h post P. aeruginosa inoculation. The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.